Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing Capsules for adult community-acquired pneumonia
ChiCTR2200059250Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 4 trial of Tanreqing Capsules in community-acquired pneumonia (CAP) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Time to normal body temperature and Lesion elimination score of pneumonia X-ray image. Started Jul 2022; status: recruiting.
02
Drugs
Tanreqing Capsules
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2200059250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059250.